Alexandria Real Estate Equities, Inc. (NYSE: ARE) is executing an ambitious disposition strategy in 2025 as it faces headwinds in the life science real estate market. The company’s 2025 disposition strategy is already well underway, with sales already made in the first quarter. As of the end of Q1 2025, the company has completed $176 […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Signup for news and special announcements!
You have successfully joined our subscriber list.
Behind Downtown Seattle's third-quarter move-outs, F5 handed back 77,000 square feet at...
ByThe RegistryNovember 7, 2026WeWork's mid-year analysis of its global membership shows companies quietly expanding the...
ByThe RegistryNovember 7, 2026The quarter's largest office sale and largest industrial sale in the Portland...
ByThe RegistryNovember 7, 2026A private buyer has paid $17.5 million for 101 Broadway, the 2017-built,...
ByThe RegistryNovember 6, 2026